Management of Reactive FTA-ABS with Non-Reactive RPR
Treat this patient with benzathine penicillin G 2.4 million units IM once weekly for 3 weeks (total 7.2 million units) for presumed late latent syphilis, unless you can document adequate prior treatment. 1
Understanding This Serologic Pattern
This combination of reactive treponemal test (FTA-ABS) with non-reactive nontreponemal test (RPR) most commonly represents one of three scenarios:
- Late latent or tertiary syphilis where nontreponemal antibodies have waned over time, which is the most clinically important possibility 1
- Previously treated syphilis where the treponemal test remains positive for life but the RPR has appropriately declined 2
- False-positive treponemal test, though this is less likely with FTA-ABS compared to other treponemal tests 1
The key diagnostic challenge is that nontreponemal tests like RPR have significantly reduced sensitivity in late-stage disease, with sensitivity dropping to only 30.7-56.9% in previously treated syphilis and 47-76% in late latent/tertiary syphilis 3, 2. This means a negative RPR does NOT rule out active late syphilis. 2
Treatment Algorithm
Step 1: Review Treatment History
If documented adequate prior treatment exists:
- Review records to confirm appropriate penicillin regimen was given for the stage of syphilis diagnosed 2
- Verify that a fourfold decline in RPR titers occurred within 6-12 months after treatment 2
- If both conditions met, no additional treatment is needed 1
If treatment history is uncertain, inadequate, or absent:
- Proceed immediately to treatment for late latent syphilis 2
- Administer benzathine penicillin G 2.4 million units IM once weekly for 3 weeks 1
Step 2: Assess for Active Disease
Before or concurrent with treatment, evaluate for clinical signs that would change management:
Red flags requiring immediate reassessment:
- Neurologic symptoms (confusion, vision changes, hearing loss, cranial nerve palsies) 2
- Ocular symptoms (uveitis, optic neuritis) 2
- New chancre or mucocutaneous lesions 2
- Cardiovascular symptoms (aortic regurgitation, chest pain) 2
If any red flags present:
- Perform lumbar puncture for CSF examination to rule out neurosyphilis 2, 1
- CSF VDRL is diagnostic when reactive, though sensitivity is only 49-87% 4
- CSF leukocyte count >5 WBCs/mm³ is a sensitive indicator for neurosyphilis 1
- If neurosyphilis confirmed, switch to aqueous crystalline penicillin G 18-24 million units per day IV for 10-14 days 2
Step 3: HIV Testing
All patients with syphilis must be tested for HIV 2
- HIV-infected patients may have atypical serologic patterns 2, 1
- HIV-infected patients require more frequent monitoring (every 3 months instead of 6 months) 2
- Consider CSF examination for all HIV-infected persons with late-latent syphilis or syphilis of unknown duration 2
Follow-Up Recommendations
For newly diagnosed and treated late latent syphilis:
- Clinical follow-up is recommended, though serologic response may be minimal 1
- Many patients will remain "serofast" with persistent low-level RPR titers (<1:8) for life 2
- The serofast state does not represent treatment failure 2
Do not perform routine serologic follow-up if:
Critical Pitfalls to Avoid
- Never rely on RPR alone to exclude late syphilis - the sensitivity is too low in late-stage disease 3, 2
- Never assume a reactive treponemal test alone means active infection - treponemal tests remain positive for life in most patients regardless of treatment 2
- Never compare titers between different test types (VDRL vs RPR) as they are not directly comparable 2, 1
- Never use treponemal tests to monitor treatment response - only nontreponemal tests (RPR/VDRL) should be used for this purpose 1
- Do not assume persistent low-titer RPR reactivity indicates treatment failure - this serofast state is common and expected 2
Special Considerations for Penicillin Allergy
If the patient has documented penicillin allergy: